Lifeward Q2 Adj. EPS $(1.46) Misses $(1.34) Estimate, Sales $6.623M Beat $6.530M Estimate
Lifeward (NASDAQ:LFWD) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1.34) by 8.96 percent. This is a 61.07 percent increase over losses of $(3.75) per share from the
Benzinga21 gün önceLFWD
Lifeward Launches Six-Mointh Pilot Program With Ottobock Care To Enable Greater Patient Access To Its ReWalk 7 Personal Exoskeleton
The agreement brings together Lifeward’s advanced personal exoskeleton technology and Ottobock Care’s established clinical expertise and regional patient care infrastructure. Through the pilot, the companies intend to
Benzingageçen ayLFWD